2025 Meta-Analysis (Khurmatullina et al.)
29 studies, 3,682 PPI patients, 2,907 controls
- • SIBO prevalence: 36.8% in PPI users vs 19.9% in controls
- • Odds ratio 2.14: about twice the odds of a positive test; results varied widely between studies
- • Duration: studies with longer average use found about 4.3 percentage points more positive tests per month. That compares studies; it can't predict your own risk
PMID: 40649078
2018 Meta-Analysis (Su et al.)
19 studies, 7,055 patients
- • Odds ratio: 1.71 for SIBO in PPI users
- • Confirmed significant association between PPI use and SIBO
PMID: 28770351
ACG Clinical Guideline: SIBO (2020)
The American College of Gastroenterology's first clinical guideline on SIBO lists PPI use as a possible risk factor for developing SIBO.
PMID: 32023228
